Literature DB >> 22110397

Peyronie's Disease: Nonsurgical Therapy Options.

Franklin E Kuehhas, Peter Weibl, Tosev Georgi, Nenad Djakovic, Ralf Herwig.   

Abstract

Peyronie's disease (PD) is a fibrous inelastic scar of the tunica albuginea, leading to penile deformity, penile curvature, shortening, narrowing, and painful erections that subsequently lead to painful or unsatisfying sexual intercourse. No consensus exists yet on the ideal management of PD. This fact is a result of our limited knowledge of its etiology and causative factors. The acute presentation of PD is treated conservatively, and surgical approaches are only attempted if severe curvature, narrowing, or indentation persists for more than 1 year; PD stability exists for at least 3 months; curvature impedes sexual intercourse; and severe penile shortening occurs. This review focuses on new developments for conservative treatment strategies for PD.

Entities:  

Keywords:  Extracorporeal shock wave therapy; Intralesional therapy; Iontophoresis; Nonsurgical therapy; Oral medication; Penile traction systems; Peyronie’s disease

Year:  2011        PMID: 22110397      PMCID: PMC3221554     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  49 in total

1.  Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study.

Authors:  M R Safarinejad
Journal:  Int J Impot Res       Date:  2010-08-19       Impact factor: 2.896

2.  Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report.

Authors:  G Biagiotti; G Cavallini
Journal:  BJU Int       Date:  2001-07       Impact factor: 5.588

3.  Treatment of Peyronie's disease with oral pentoxifylline.

Authors:  William O Brant; Robert C Dean; Tom F Lue
Journal:  Nat Clin Pract Urol       Date:  2006-02

4.  International Conference on Peyronie's disease advances in basic and clinical research. March 17-19, 1993. Introduction.

Authors:  C J Devine
Journal:  J Urol       Date:  1997-01       Impact factor: 7.450

5.  Nicardipine vs. saline injection as treatment for Peyronie's disease: a prospective, randomized, single-blind trial.

Authors:  Jintetsu Soh; Akihiro Kawauchi; Noriyuki Kanemitsu; Yoshio Naya; Atsushi Ochiai; Yasuyuki Naitoh; Terufumi Fujiwara; Kazumi Kamoi; Tsuneharu Miki
Journal:  J Sex Med       Date:  2010-11       Impact factor: 3.802

6.  A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease.

Authors:  Mohammad Reza Safarinejad; Majid Ali Asgari; Seyyed Yousof Hosseini; Farid Dadkhah
Journal:  BJU Int       Date:  2009-10-26       Impact factor: 5.588

7.  Penile sonographic and clinical characteristics in men with Peyronie's disease.

Authors:  James F Smith; William O Brant; Vincent Fradet; Alan W Shindel; Eric Vittinghoff; Thomas Chi; Yun-Ching Huang; Cole B Davis; Simon Conti; Tom F Lue
Journal:  J Sex Med       Date:  2009-08-28       Impact factor: 3.802

8.  Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study.

Authors:  William P Fitch; W Jerry Easterling; Robert L Talbert; Michael J Bordovsky; Michael Mosier
Journal:  J Sex Med       Date:  2007-03       Impact factor: 3.802

9.  Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study.

Authors:  Laurence A Levine; Mark Newell; Frederick L Taylor
Journal:  J Sex Med       Date:  2008-03-26       Impact factor: 3.802

10.  New sonographic aspects of peyronie disease.

Authors:  Décio Prando
Journal:  J Ultrasound Med       Date:  2009-02       Impact factor: 2.153

View more
  4 in total

1.  Rationale of combination therapy with antioxidants in medical management of Peyronie's disease: results of clinical application.

Authors:  Gianni Paulis; Andrea Paulis; Gennaro Romano; Davide Barletta; Andrea Fabiani
Journal:  Res Rep Urol       Date:  2017-07-20

2.  Recurrent Penile Fracture-Case Report and Alternative Surgical Approach.

Authors:  Bruno Nascimento; Giuliano B Guglielmetti; Eduardo P Miranda; Renato F Ivanovic; Carlos A Batagello; William C Nahas; Miguel Srougi; José Cury
Journal:  Sex Med       Date:  2018-05-03       Impact factor: 2.491

Review 3.  Penile traction therapy for Peyronie's disease-what's the evidence?

Authors:  Mustafa Faruk Usta; Tumay Ipekci
Journal:  Transl Androl Urol       Date:  2016-06

4.  Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study.

Authors:  Gianni Paulis; Davide Barletta; Paolo Turchi; Antonio Vitarelli; Giuseppe Dachille; Andrea Fabiani; Romano Gennaro
Journal:  Res Rep Urol       Date:  2015-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.